Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung


  • Ibrahim El-Battrawy - , BG Universitätsklinikum Bergmannsheil Bochum (Autor:in)
  • David Tenbrink - , BG Universitätsklinikum Bergmannsheil Bochum (Autor:in)
  • Boldizsar Kovacs - , Universitätsklinikum Schleswig-Holstein Campus Lübeck (Autor:in)
  • Tobias C Dreher - , Universität Mannheim, Universitätsklinikum Heidelberg (Autor:in)
  • Christian Blockhaus - , Helios Klinikum Pirna (Autor:in)
  • Norbert Klein - , Helios Klinikum Pirna (Autor:in)
  • Dong-In Shin - , Helios Klinikum Pirna (Autor:in)
  • Mido Hijazi - , Klinik und Poliklinik für Neurochirurgie, Universitäts GefäßCentrum (Autor:in)
  • Stephanie Rosenkaimer - , Universitätsmedizin Mannheim (Autor:in)
  • Thomas Beiert - , Universitätsmedizin Mannheim (Autor:in)
  • Mohammad Abumayyaleh - , Universitätsmedizin Mannheim (Autor:in)
  • Ardan Muammer Saguner - , Universitätsklinikum Schleswig-Holstein Campus Lübeck (Autor:in)
  • Jacqueline Kowitz - , Universitätsmedizin Mannheim (Autor:in)
  • Julia W Erath - , Johann Wolfgang Goethe-Universität Frankfurt am Main (Autor:in)
  • Firat Duru - , Universitätsklinikum Schleswig-Holstein Campus Lübeck (Autor:in)
  • Andreas Mügge - , BG Universitätsklinikum Bergmannsheil Bochum (Autor:in)
  • Assem Aweimer - , BG Universitätsklinikum Bergmannsheil Bochum (Autor:in)
  • Ibrahim Akin - , Universitätsmedizin Mannheim (Autor:in)


BACKGROUND: Wearable cardioverter defibrillators (WCD) are used as a 'bridging' technology in patients, who are temporarily at high risk for sudden cardiac death (SCD). Several factors should be taken into consideration, for example patient selection, compliance and optimal drug treatment, when WCD is prescribed. We aimed to present real-world data from seven centres from Germany and Switzerland according to age differences regarding the outcome, prognosis, WCD data and compliance.

MATERIALS AND METHODS: Between 04/2012 and 03/2021, 1105 patients were included in this registry. Outcome data according to age differences (old ≥45 years compared to young <45 years) were analysed. At young age, WCDs were more often prescribed due to congenital heart disease and myocarditis. On the other hand, ischaemic cardiomyopathy (ICM) was more present in older patients. Wear days of WCD were similar between both groups (p = .115). In addition, during the WCD use, documented arrhythmic life-threatening events were comparable [sustained ventricular tachycardia: 5.8% vs. 7.7%, ventricular fibrillation (VF) .5% vs. .6%] and consequently the rate of appropriate shocks was similar between both groups. Left ventricular ejection fraction improvement was documented over follow-up with a better improvement in younger patients as compared to older patients (77% vs. 63%, p = .002). In addition, at baseline, the rate of atrial fibrillation was significantly higher in the older age group (23% vs. 8%; p = .001). The rate of permanent cardiac implantable electronic device implantation (CiED) was lower in the younger group (25% vs. 36%, p = .05). The compliance rate defined as wearing WCD at least 20 h per day was significantly lower in young patients compared to old patients (68.9% vs. 80.9%, p < .001). During the follow-up, no significant difference regarding all-cause mortality or arrhythmic death was documented in both groups. A low compliance rate of wearing WCD is predicted by young patients and patients suffering from non-ischaemic cardiomyopathies.

CONCLUSION: Although the compliance rate in different age groups is high, the average wear hours tended to be lower in young patients compared to older patients. The clinical events were similar in younger patients compared to older patients.


FachzeitschriftEuropean journal of clinical investigation
PublikationsstatusVeröffentlicht - Juli 2023

Externe IDs

Scopus 85150451800



  • Humans, Aged, Middle Aged, Stroke Volume, Ventricular Function, Left, Death, Sudden, Cardiac/epidemiology, Myocardial Ischemia/therapy, Registries, Atrial Fibrillation/complications, Defibrillators/adverse effects, Wearable Electronic Devices, Retrospective Studies